Viewing Study NCT01929603


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2025-12-25 @ 4:49 PM
Study NCT ID: NCT01929603
Status: COMPLETED
Last Update Posted: 2017-01-16
First Post: 2013-08-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module